Clinical Trials Logo

Clinical Trial Summary

Primary objective:

- To evaluate change in total volume of all nodules.

Secondary objectives:

- To evaluate change in goiter volume after a 12-months treatment, number of nodules and echogenicity of nodules.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00277589
Study type Interventional
Source Sanofi
Contact
Status Completed
Phase Phase 4
Start date May 2004
Completion date December 2008

See also
  Status Clinical Trial Phase
Completed NCT01588288 - Galectin 3 Dosage in Diagnosis of Nodular and Multinodular Goiter N/A
Completed NCT03072654 - Tracheal Anatomy After Thyroidectomy N/A
Completed NCT02205801 - Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy N/A